Table 1 Patient characteristics
Characteristics | All patients | FP group | F group | p-value |
|---|---|---|---|---|
(n = 129) | (n = 64) | (n = 65) | ||
No. (%) | No. (%) | No. (%) | ||
Age (years) | ||||
Median (range) | 65 (24–94) | 62 (27–94) | 67 (24–89) | 0.02 |
< 65 | 61 (47) | 36 (56) | 25 (38) | 0.04 |
> 65 | 68 (53) | 28 (44) | 40 (62) | |
Sex | ||||
Male | 68 (53) | 33 (52) | 35 (54) | 0.80 |
Female | 61 (47) | 31 (48) | 30 (46) | |
ECOG PS | ||||
0 | 9 (7) | 4 (6) | 5 (8) | |
1 | 68 (53) | 41 (64) | 27 (42) | |
2 | 44 (34) | 16 (25) | 28 (43) | |
3 | 7 (5) | 2 (3) | 5 (8) | |
4 | 1 (1) | 1 (2) | 0 (0) | |
0–1 | 77 (60) | 45 (70) | 32 (49) | 0.01 |
2–4 | 52 (40) | 19 (30) | 33 (51) | |
Histology | ||||
Intestinal | 22 (17) | 10 (16) | 12 (18) | 0.81 |
Diffuse | 102 (79) | 52 (81) | 50 (77) | |
Unknown | 5 (4) | 2 (3) | 3 (5) | |
Disease status | ||||
Advanced | 120 (93) | 58 (91) | 62 (95) | 0.29 |
Recurrent | 9 (7) | 6 (9) | 3 (5) | |
Primary tumor | ||||
Presence | 113 (88) | 54 (84) | 59 (91) | 0.27 |
Absence | 16 (12) | 10 (16) | 6 (9) | |
Primary site | ||||
Stomach | 123 (95) | 59 (92) | 64 (98) | 0.09 |
GEJ | 6 (5) | 5 (8) | 1 (2) | |
No. of metastatic sites | ||||
1–2 | 100 (78) | 49 (77) | 51 (78) | 0.80 |
> 3 | 29 (22) | 15 (23) | 14 (22) | |
Target lesion | ||||
Presence | 56 (43) | 24 (38) | 32 (49) | 0.18 |
Absence | 73 (57) | 40 (62) | 33 (51) | |
Subtype of SPM | ||||
Massive ascites | 62 (48) | 39 (61) | 23 (35) | 0.01 |
Inadequate oral intake | 35 (27) | 16 (25) | 19 (29) | |
Both | 32 (25) | 9 (14) | 23 (35) | |
Serum albumin level (g/ml) | ||||
Median (range) | 3.1 (1.8–4.4) | 3.1 (1.8–4.3) | 3.1 (1.8–4.4) | 0.87 |
Serum CRP level (mg/dl) | ||||
Median (range) | 2.2 (0.0–24.0) | 1.8 (0.1–20.7) | 2.6 (0.0–24.0) | 0.86 |